2 August 2019

READ MOREAkston Biosciences Completes Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

25 June 2019

READ MOREAkston Biosciences Receives NIDDK Phase IIb Grant

26 May 2019

READ MOREAkston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility

10 May 2019

READ MOREAkston Biosciences Completes Convertible Note Financing

17 May 2018

READ MOREAkston Biosciences Completes Series D Preferred Stock Financing

22 February 2018

READ MOREAkston Biosciences Awarded Phase II SBIR by NIH/NIDDK

16 March 2017

READ MOREHelmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes

12 January 2015

READ MOREUltra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs